Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 NKTR-102 Demonstrates Synergistic Anti-Tumor Activity in Combination with Pegylated Liposomal Doxorubicin in Platinum-Resistant Ovarian Cancer Nov 15, 2011 Positive Data for Nektar's New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011 Nov 14, 2011 Nektar Therapeutics Reports Third Quarter 2011 Financial Results Nov 02, 2011 Nektar to Announce Financial Results for the Third Quarter of 2011 on Wednesday, November 2, 2011, After Close of U.S.-Based Financial Markets Oct 26, 2011 Nektar Presents Positive Data for Novel Opioid Analgesic, NKTR-181, at the 2011 American Academy of Pain Management Annual Meeting Sep 21, 2011 Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the UBS 2011 Global Life Sciences Conference in New York City Sep 14, 2011 Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium Sep 09, 2011 Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain Sep 08, 2011 Nektar Therapeutics Reports Second Quarter 2011 Financial Results Aug 04, 2011 Nektar to Announce Financial Results for the Second Quarter of 2011 on Thursday, August 4, 2011, After Close of U.S.-Based Financial Markets Jul 27, 2011 Pagination First page « first Previous page ‹ previous … Page 33 Page 34 Page 35 Page 36 Current page 37 Page 38 Page 39 Page 40 Page 41 … Next page next › Last page last »